University College Hospitals NHS Foundation Trust
London, United Kingdom
Location status: Recruiting
NCT Number: NCT04661059
Knowledge about abnormal organ development is important to understand pathology and to develop novel treatment approaches for individuals with congenital and acquired disease. Most of our current understanding is based on examination of tissues from the embryo and early fetus, collected from women undergoing termination of pregnancy in the first trimester (third) of pregnancy. There is very little known about normal and abnormal organ development from a developmental perspective during the crucial last two-thirds of pregnancy when much remodelling of fetal tissues occurs. We aim to collect tissue from a variety of developing fetal organs in the last two-thirds of pregnancy from women who decide to undergo a termination of pregnancy and who wish to undergo a clinical fetal postmortem (PM) examination.
Interested in participating?
Request Info18 year and older
All sexes
Observational
London, United Kingdom
Location status: Recruiting
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Immediately after tissue collection
Immunofluorescence staining
Contact information is provided by the study sponsor or research team.
University College London Hospitals
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05673499
Cerebral Desaturation, Congenital Disorders
New York, United States
View Trial DetailsNCT04405700
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Eldoret, Kenya
View Trial DetailsNCT05749419
Behavior, Compliance, Patient
Jerusalem, Israel
View Trial DetailsNCT06721871
Congenital Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Boston, Massachusetts, United States
View Trial Details